NIH-funded research NIH-funded research

How cell receptors control blood-vessel inflammation

Official title: Cell signaling by G protein-coupled receptors

Funded at University of California, San Diego · NIH-11522501 · Data updated 2026-11-12

This work looks at how certain cell receptors keep signaling from inside cells and how that can cause inflammation in blood vessels for people with vascular conditions.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego
NIH-funded
Lab location1 site (La Jolla, United States)
Project startJune 1, 2018
Project endMarch 31, 2028
Funding year2026
Award (this year)$40,798
NIH project number3R35GM127121-09S1
Project IDNIH-11522501 on NIH RePORTER

Who could benefit from this research

Could help

People with vascular inflammatory conditions such as atherosclerosis, vasculitis, or other cardiovascular diseases would be the most relevant group for future studies arising from this work.

Less likely to help

People seeking immediate treatment or those without vascular inflammation are unlikely to receive direct benefit from this basic laboratory research.

What this research studies

The team at UC San Diego studies G protein-coupled receptors (GPCRs), common cell receptors that can keep sending signals after they are taken into the cell. They will identify how adding or removing a small tag called ubiquitin controls a key inflammatory pathway (p38 MAPK) and how the regulator ARRDC3 acts on endosomes. The lab uses molecular and cell-based experiments and likely animal models to find the proteins and steps that drive vascular inflammation. Learning these steps may point to new targets for drugs that reduce harmful inflammation in blood vessels.

Why it matters

Potential benefit: If successful, this work could reveal new drug targets to prevent or reduce blood-vessel inflammation that contributes to heart attack, stroke, and other vascular diseases.

How similar studies have gone: Prior lab studies have shown GPCRs can signal from endosomes and link to inflammation, but turning those findings into new therapies is still early and largely untested.

Where this research is happening

  • University of California, San Diego
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Trejo, Joann — University of California, San Diego
  • Study coordinator: Trejo, Joann

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.